Back to the news

Companies

Divi's Laboratories shares gain 6% after JPMorgan upgrade; Goldman raises earnings estimates after strong Q2

Reported by: CNBC TV18 ·

WhatsApp

Divi's Laboratories

Summary

CNBC TV18 reported that Divi's Laboratories shares gained 6% after JPMorgan upgraded the stock and Goldman Sachs raised its earnings estimates following a strong second quarter. CNBC TV18 also reported that Motilal said the company is well positioned to win business in custom synthesis, citing its capabilities across peptides, contrast media and generics and its large-scale commercial manufacturing. Q2 is the July to September quarter, the second quarter of India's financial year. These are the analysts' views, not Hypeless's.

AI summary of what CNBC TV18 and NDTV Profit reported. AI can make mistakes. Read the full story on CNBC TV18

Learn: What is an exchange filing?

Sources

Every outlet that reported this story. Each link opens the outlet's own article.

What each outlet wrote

The same news, in each outlet's own headline. Open one to read their full story.

CNBC TV18  · · Tone +3

Divi's Laboratories shares gain 6% after JPMorgan upgrade; Goldman raises earnings estimates after strong Q2

Motilal said the company is well-positioned to secure business in the custom synthesis segment, given its scientific capabilities across peptides, contrast media and generics, large-scale commercial manufacturing…

Some headlines quote an analyst. Those views are theirs, not ours.

Key terms

Words in this story, explained in plain language in our Learn pages.

  • earnings

    Revenue, profit, margins and EPS: what the numbers in a quarterly result mean, why year-on-year and quarter-on-quarter differ, and what a headline can leave out.

    Learn: How to read a company's results

Earlier coverage

What outlets reported about the same company before this story, newest first.

Ask Hypeless about this story

Ask what it means, what a term in it means, or what other outlets said. Answers use only these outlets' headlines.

Ask Hypeless